Ara sangivamycin
Latest Information Update: 13 Nov 2003
Price :
$50 *
At a glance
- Originator Unknown
- Class Antivirals
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Viral infections
Most Recent Events
- 13 Nov 2003 Discontinued for Viral infections (unspecified route)
- 27 Jul 1998 No-Development-Reported for Viral infections (Unknown route)